CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent
about
Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular functionHypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.Vascular actions of 20-HETE20-HETE and blood pressure regulation: clinical implicationsEpoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.The role of 20-HETE in androgen-mediated hypertension.Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertensionSoluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter BindingCyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes.Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats.6β-Hydroxytestosterone, a Cytochrome P450 1B1-Testosterone-Metabolite, Mediates Angiotensin II-Induced Renal Dysfunction in Male Mice.Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/220-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats.20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertensionRole of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.Modulation of cardiac cytochrome P450 in patients with heart failure.Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertensionThe Blood Pressure-Lowering Effect of 20-HETE Blockade in Cyp4a14(-/-) Mice Is Associated with Natriuresis.Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.20-HETE: Hypertension and Beyond20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats
P2860
Q26849271-ECEB3498-8A3D-4946-BC41-B9C31044BE28Q27343126-656FD420-5F1A-473D-A282-1BDF4D3C2964Q28259468-E8375553-3E99-4949-B2E2-3BC52C436D7DQ28288942-3F695293-4F8D-45DB-8359-AE5DA6DE73E0Q33904690-5AE36FE2-0CDC-40D7-8E3F-B004B1E310C0Q34196923-A9265001-077A-4200-98DC-6F412E8E1438Q34342711-0C4D3935-9D87-444C-998D-FF35AEE48E83Q34454880-C23C634A-E73A-467F-99F4-F2E0871F8A70Q35611363-46273580-DBA3-4884-80D1-6871FC036236Q35817958-A8197F17-98AC-4261-B3FA-149564AB4B9EQ36074375-67BEBC6F-7399-497E-947A-B42F714FE6EFQ36618716-64B236BD-9DEB-4278-A465-EAB53E3B6020Q36744134-4A58EE72-4261-4EE8-B447-5490A07208C1Q36757000-349A5163-6915-4D0F-AF09-BD4E8A542138Q36803513-49C995F3-E77B-48B6-BC6A-D26C706F1478Q37008916-35E965DF-E726-4176-9DE7-9B2485E8C83FQ37139461-92A93274-D2C0-40DF-8FE9-8FA42BF9FE8AQ37142503-4365B14F-9C56-4207-9CEA-624E4664585AQ38100223-0211B41F-E3C6-4856-B456-E854C712306EQ38175461-430AD9C3-5490-4889-B8A6-B75BCA1F5792Q38693289-BC00E173-6146-4240-A9D5-2F082486B09CQ39431317-414E439E-E959-47E3-A19E-DB8E167E3F8CQ42115749-240A7E69-9240-4364-A1C8-0621E5050E5DQ42151348-2506E286-30CA-40CC-AED6-C06F3E9B5964Q42333698-33CB363F-4EFD-421C-A62F-C6352768A2A7Q47799305-CDC6E175-5F1A-477A-B5E7-E3B0240A6AE0Q50081720-022240C6-1E97-4068-A244-6C32506E7732Q57210352-5076C090-F671-428E-A6DB-915B71287720Q58748872-62074D6A-546A-4177-96B0-D928A20E8E7C
P2860
CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@ast
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@en
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@nl
type
label
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@ast
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@en
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@nl
prefLabel
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@ast
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@en
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@nl
P2093
P2860
P1433
P1476
CYP4A2-induced hypertension is ...... - and angiotensin II-dependent
@en
P2093
Cheng-Chia Wu
Jennifer Cheng
Katherine Gotlinger
Kazuyoshi Inoue
Komal Sodhi
Michal L Schwartzman
Mohan Goli
Nader G Abraham
P2860
P304
P356
10.1161/HYPERTENSIONAHA.110.154559
P407
P577
2010-09-13T00:00:00Z